In Second Review Of CeraVe ‘#1 Recommended’ Claim, L’Oreal’s Survey ‘Substantially More Reliable’
Executive Summary
With new evidence providing “reasonable basis” for claim support, National Advertising Division reverses course on 2021 decision on J&J challenge of L’Oreal USA’s use of "#1 recommended by dermatologist" claims.
You may also be interested in...
Sanofi Eyes Using Zantac 360 Most-Recommended Ad Claim With Disclaimer Highlighting Ingredient
Industry self-regulation group’s appeals board agrees with investigative division’s finding Sanofi didn’t support Zantac 360 “#1 doctor recommended” ad claims. Board declines to consider whether “#1 doctor recommended H2 active ingredient” with “based on generic acid reducer recommendations” disclaimer is supported.
Once Was Enough For J&J In Supporting Neutrogena ‘#1 Recommended’ Advertising
J&J Consumer appeals National Advertising Division decision, arguing a “#1 claim” for its Neutrogena personal care line challenged by L’Oréal USA is materially similar to one that NAD attorneys found it supported more than a decade ago.
Survey Says! J&J Prevails Over L’Oreal In NAD ‘#1 Dermatologist Recommended’ Dispute
L’Oreal USA will appeal a National Advertising Division decision advising it to stop claiming that CeraVe is the “#1 dermatologist recommended skincare brand.” J&J challenged the claim, taking issue with the underlying dermatologist survey.